[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1990 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | |||||
1991 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | |||||
1992 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | |||||
1993 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | |||||
1994 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | |||||
1995 | 0 | 0.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | |||||
1996 | 0 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | |||||
1997 | 0 | 0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | |||||
1998 | 0 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.15 | |||||
1999 | 0 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
2000 | 0 | 0.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | |||||
2001 | 0 | 0.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | |||||
2002 | 0 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | |||||
2003 | 0 | 0.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | |||||
2004 | 0 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.27 | |||||
2005 | 0 | 0.49 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 | |||||
2006 | 0 | 0.48 | 0 | 0 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0.26 | |||||
2007 | 0 | 0.4 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | 0.22 | |||||
2008 | 0 | 0.45 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 2 | 0 | 0 | 0.23 | |||||
2009 | 0 | 0.43 | 0 | 0 | 2 | 5 | 0 | 0 | 1 | 3 | 0 | 0 | 0.23 | |||||
2010 | 0.33 | 0.37 | 0.11 | 0.2 | 4 | 9 | 0 | 1 | 1 | 3 | 1 | 5 | 1 | 0 | 0 | 0.19 | ||
2011 | 0 | 0.47 | 0 | 0 | 3 | 12 | 4 | 1 | 6 | 8 | 0 | 0 | 0.25 | |||||
2012 | 0 | 0.5 | 0 | 0 | 3 | 15 | 0 | 1 | 7 | 10 | 0 | 0 | 0.26 | |||||
2013 | 0.17 | 0.52 | 0.07 | 0.08 | 0 | 15 | 0 | 1 | 2 | 6 | 1 | 13 | 1 | 0 | 0 | 0.24 | ||
2014 | 0 | 0.55 | 0.11 | 0.08 | 3 | 18 | 4 | 2 | 4 | 3 | 12 | 1 | 0 | 1 | 0.33 | 0.28 | ||
2015 | 1 | 0.54 | 0.17 | 0.23 | 5 | 23 | 5 | 4 | 8 | 3 | 3 | 13 | 3 | 1 | 25 | 1 | 0.2 | 0.28 |
2016 | 0 | 0.58 | 0.04 | 0.07 | 4 | 27 | 0 | 1 | 9 | 8 | 14 | 1 | 0 | 0 | 0.29 | |||
2017 | 0.11 | 0.6 | 0.15 | 0.07 | 7 | 34 | 4 | 5 | 14 | 9 | 1 | 15 | 1 | 2 | 40 | 1 | 0.14 | 0.3 |
2018 | 0.27 | 0.62 | 0.23 | 0.42 | 9 | 43 | 3 | 10 | 24 | 11 | 3 | 19 | 8 | 1 | 10 | 2 | 0.22 | 0.33 |
IF: | Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192. Full description at Econpapers || Download paper | 5 |
2 | 2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576. Full description at Econpapers || Download paper | 3 |
3 | 2018 | The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009. Full description at Econpapers || Download paper | 3 |
4 | 2014 | The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050. Full description at Econpapers || Download paper | 3 |
5 | 2017 | Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802. Full description at Econpapers || Download paper | 2 |
6 | 2014 | The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cockcroft, L ; Sussex, J ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518. Full description at Econpapers || Download paper | 2 |
7 | 2015 | Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660. Full description at Econpapers || Download paper | 2 |
8 | 2018 | A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Shaw, B ; Hernandez-Villafuerte, K ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002015. Full description at Econpapers || Download paper | 1 |
9 | 2012 | The Many Faces of Innovation. (2012). Sussex, J ; Mordoh, A ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000154. Full description at Econpapers || Download paper | 1 |
10 | 2017 | Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784. Full description at Econpapers || Download paper | 1 |
11 | 2016 | Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Cubi-Molla, Patricia. In: Consulting Reports. RePEc:ohe:conrep:001699. Full description at Econpapers || Download paper | 1 |
12 | 2008 | Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236. Full description at Econpapers || Download paper | 1 |
13 | 2017 | Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933. Full description at Econpapers || Download paper | 1 |
14 | 2010 | Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Puig-Peiro, R ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000212. Full description at Econpapers || Download paper | 1 |
15 | 2017 | Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Zamora, Bernarda ; Garau, Martina ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818. Full description at Econpapers || Download paper | 1 |
16 | 2015 | Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cole, Amanda ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595. Full description at Econpapers || Download paper | 1 |
# | Year | Title | Cited |
---|---|---|---|
1 | 2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192. Full description at Econpapers || Download paper | 4 |
2 | 2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576. Full description at Econpapers || Download paper | 3 |
3 | 2018 | The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009. Full description at Econpapers || Download paper | 3 |
4 | 2015 | Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660. Full description at Econpapers || Download paper | 2 |
5 | 2017 | Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802. Full description at Econpapers || Download paper | 2 |
Year | Title | |
---|---|---|
2018 | New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes. (2018). Varnava, Alice ; Routledge, Philip A ; Hughes, Dyfrig A ; Samuels, Karen ; Bracchi, Robert. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-018-0632-7. Full description at Econpapers || Download paper | |
2018 | Cost-Effectiveness Thresholds: the Past, the Present and the Future. (2018). Thokala, Praveen ; Tong, Thaison ; Leech, Ashley A ; Ochalek, Jessica. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0606-1. Full description at Econpapers || Download paper | |
2018 | The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2018 | Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals. (2018). Lorgelly, Paula ; Cole, Amanda ; Sullivan, R ; Towse, A. In: Research Papers. RePEc:ohe:respap:002030. Full description at Econpapers || Download paper | |
2018 | Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2017 | Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study. (2017). Garau, Martina ; Garrison, L ; Towse, T ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001781. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2015 | Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Pistollato, M ; Dellamano, R ; Mestre-Ferrandiz, J. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers || Download paper |